CA2505151C - Evaluation d'etat - Google Patents

Evaluation d'etat Download PDF

Info

Publication number
CA2505151C
CA2505151C CA2505151A CA2505151A CA2505151C CA 2505151 C CA2505151 C CA 2505151C CA 2505151 A CA2505151 A CA 2505151A CA 2505151 A CA2505151 A CA 2505151A CA 2505151 C CA2505151 C CA 2505151C
Authority
CA
Canada
Prior art keywords
subject
data
status
parameters
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2505151A
Other languages
English (en)
Other versions
CA2505151A1 (fr
Inventor
Richard Bruce Brandon
Mervyn Rees Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunexpress Pty Ltd
Original Assignee
Immunexpress Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunexpress Pty Ltd filed Critical Immunexpress Pty Ltd
Publication of CA2505151A1 publication Critical patent/CA2505151A1/fr
Application granted granted Critical
Publication of CA2505151C publication Critical patent/CA2505151C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/40—Encryption of genetic data
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioethics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Primary Health Care (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention se rapporte à un procédé d'évaluation de l'état d'un sujet. En particulier, ce procédé consiste à obtenir des données relatives au sujet, qui incluent des valeurs respectives pour chacun des paramètres d'un ensemble de paramètres, lesdites valeurs de paramètres étant représentatives de l'état biologique courant du sujet. Les données relatives au sujet sont comparées à des données préétablies qui incluent des valeurs pour au moins certains des paramètres et une indication d'état pathologique. L'état du sujet, et en particulier, la présence et/ou l'absence d'un ou plusieurs états pathologiques, peut alors être évalué en fonction des résultats de la comparaison.
CA2505151A 2002-11-14 2003-11-14 Evaluation d'etat Expired - Fee Related CA2505151C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002952696 2002-11-14
AU2002952696A AU2002952696A0 (en) 2002-11-14 2002-11-14 Status determination
PCT/AU2003/001517 WO2004044236A1 (fr) 2002-11-14 2003-11-14 Evaluation d'etat

Publications (2)

Publication Number Publication Date
CA2505151A1 CA2505151A1 (fr) 2004-05-27
CA2505151C true CA2505151C (fr) 2013-07-30

Family

ID=28796082

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2505151A Expired - Fee Related CA2505151C (fr) 2002-11-14 2003-11-14 Evaluation d'etat

Country Status (5)

Country Link
EP (1) EP1581658A4 (fr)
AU (1) AU2002952696A0 (fr)
CA (1) CA2505151C (fr)
NZ (1) NZ539578A (fr)
WO (1) WO2004044236A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11450121B2 (en) * 2017-06-27 2022-09-20 The Regents Of The University Of California Label-free digital brightfield analysis of nucleic acid amplification

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2359689B1 (fr) 2002-09-27 2015-08-26 The General Hospital Corporation Dispositif microfluidique pour la séparation de cellules et usage du dispositif
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2007084719A2 (fr) * 2006-01-19 2007-07-26 Valenti Samuel R Systeme et procedes de diagnostic medical
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (fr) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse de cellules rares utilisant la division d'échantillons et les marqueurs d'ADN
EP2029779A4 (fr) 2006-06-14 2010-01-20 Living Microsystems Inc Utilisation de génotypage snp fortement parallèle pour diagnostic fétal
NZ577683A (en) * 2006-12-01 2011-12-22 Ameritox Ltd Method and apparatus for generating toxicology reports
WO2008129458A1 (fr) * 2007-04-18 2008-10-30 Koninklijke Philips Electronics N.V. Procédé appliqué éà des spectres de fréquences d'adn pour exploration de données
EP2071339A3 (fr) * 2007-12-12 2015-05-20 Sysmex Corporation Système pour fournir des informations de test animal et procédé pour fournir des informations de test animal
CA3069082C (fr) 2008-09-20 2022-03-22 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic non effractif d'aneuploidie foetale par sequencage
US20130226621A1 (en) * 2010-11-01 2013-08-29 Koninklijke Philips Electronics N.V. In vitro diagnostic testing including automated brokering of royalty payments for proprietary tests
CN104903727B (zh) 2012-11-08 2019-10-22 马克法兰伯尼特医学研究与公共健康协会有限公司 诊断、预后、治疗和筛选方案
AU2014284124B2 (en) 2013-06-20 2020-03-12 Immunexpress Pty Ltd Biomarker identification
ES2542277B1 (es) * 2014-12-23 2016-05-11 Soler Gabinete De Ingeniería S.L. Sistema de detección y aviso de cólicos en equinos
CN110851414B (zh) * 2019-11-06 2023-05-05 云南艾拓信息技术有限公司 一种以聚类法进行边界数据分析的方法及其系统
JP6989997B1 (ja) * 2020-03-23 2022-02-14 株式会社Peco 動物患者用検査提案システム、動物患者用検査提案端末、動物患者用検査提案プログラム及び動物患者用検査提案方法
CN114838796B (zh) * 2022-04-29 2023-06-09 合肥市正茂科技有限公司 视觉辅助车辆动态称重方法与称重系统
CN115582631B (zh) * 2022-09-23 2024-10-08 深圳市汇川技术股份有限公司 飞行加工方法、装置、激光平面切割设备及介质
US11902129B1 (en) 2023-03-24 2024-02-13 T-Mobile Usa, Inc. Vendor-agnostic real-time monitoring of telecommunications networks

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0834575B1 (fr) 1990-12-06 2001-11-28 Affymetrix, Inc. (a Delaware Corporation) Identification d'acides nucléiques dans des échantillons
CA2124087C (fr) 1991-11-22 2002-10-01 James L. Winkler Techniques combinees pour la synthese de polymeres
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5658744A (en) * 1994-07-22 1997-08-19 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying patients having an altered immune status
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
CA2359352C (fr) * 1999-02-09 2004-09-21 Illumina, Inc. Traitement informatise d'informations dans des groupements ordonnes de maniere aleatoire
US6647341B1 (en) * 1999-04-09 2003-11-11 Whitehead Institute For Biomedical Research Methods for classifying samples and ascertaining previously unknown classes
CA2378008A1 (fr) * 1999-06-28 2001-04-12 Source Precision Medicine, Inc. Systemes et techniques permettant de caracteriser un etat ou un agent biologique par expression genique calibree
US6180351B1 (en) * 1999-07-22 2001-01-30 Agilent Technologies Inc. Chemical array fabrication with identifier
DE19935043B4 (de) * 1999-07-26 2005-12-01 Moeller Gmbh Schaltungsanordnung zur elektronischen Steuerung einer Antriebsspule
AU6939700A (en) * 1999-08-27 2001-03-26 Pluvita Corporation System and method for genomic and proteomic human disease assessment via expression profile comparison
AU7579900A (en) * 1999-09-15 2001-04-17 Luminex Corporation Creation of a database of biochemical data and methods of use
WO2001028415A1 (fr) * 1999-10-15 2001-04-26 Dodds W Jean Diagnostic de sante animale
US6868342B2 (en) * 2000-10-13 2005-03-15 The Brigham & Women's Hospital, Inc. Method and display for multivariate classification
AU3118602A (en) * 2000-10-18 2002-04-29 Genomic Health Inc Genomic profile information systems and methods
WO2002073504A1 (fr) * 2001-03-14 2002-09-19 Gene Logic, Inc. Systeme et procede d'extraction et d'utilisation de donnees d'expression genique provenant de multiples sources
AUPR480901A0 (en) * 2001-05-04 2001-05-31 Genomics Research Partners Pty Ltd Diagnostic method for assessing a condition of a performance animal

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11450121B2 (en) * 2017-06-27 2022-09-20 The Regents Of The University Of California Label-free digital brightfield analysis of nucleic acid amplification

Also Published As

Publication number Publication date
CA2505151A1 (fr) 2004-05-27
WO2004044236A1 (fr) 2004-05-27
NZ539578A (en) 2007-12-21
EP1581658A4 (fr) 2007-12-26
EP1581658A1 (fr) 2005-10-05
AU2002952696A0 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
US20110231106A1 (en) Status determination
CA2505151C (fr) Evaluation d'etat
US20040236516A1 (en) Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression
Der et al. Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis
US20200347444A1 (en) Gene-expression profiling with reduced numbers of transcript measurements
US7062076B1 (en) Artificial intelligence system for genetic analysis
US7729864B2 (en) Computer systems and methods for identifying surrogate markers
US20140040264A1 (en) Method for estimation of information flow in biological networks
EP2556185B1 (fr) Profilage de l'expression génique faisant appel à un nombre réduit de mesures concernant des transcrits
US20200190597A1 (en) Identification of tumors
US20110312520A1 (en) Methods and compositions for diagnosing conditions
CA3160566A1 (fr) Systemes et methodes de prediction de l'etat d'une deficience de recombinaison homologue d'un specimen
US20190100809A1 (en) Algorithms for disease diagnostics
AU2016341281A1 (en) Methods and systems for assessing infertility as a result of declining ovarian reserve and function
AU2003275800B2 (en) Status determination
Csillag et al. Microarrays and Crohn's disease: collecting reliable information
AU2002252820A1 (en) Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression
Knudtson et al. The ABRF MARG microarray survey 2005: taking the pulse of the microarray field
Mansfield et al. Arrays amaze: unraveling the transcriptisome in transplantation
KR101244543B1 (ko) 17-β 에스트라디올에 대한 노출 여부 판단용판단용 유전자 마커군, 마이크로어레이 칩 및 이를 이용한 판단 방법
Miller et al. Microarrays in systems neurobiology and translational neuroscience–From genome research to clinical applications
HK1179311A (en) Gene-expression profiling with reduced numbers of transcript measurements
HK1179311B (en) Gene-expression profiling with reduced numbers of transcript measurements
HK1182452B (en) Methods and compositions for diagnosing conditions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20171114